Molgramostim shows promise in rare lung disease treatment
LANGHORNE, Pa. - Savara Inc. (NASDAQ:SVRA), a biopharmaceutical company specializing in rare respiratory diseases with a ...
How the virus behind COVID-19 can harm your blood vessels and your heart
The same mechanisms involved in COVID-related cardiovascular events are responsible for COVID-related myocarditis.